Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIACINAMIDE Cause Intentional product use issue? 159 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Intentional product use issue have been filed in association with NIACINAMIDE (PUVIDA SNOW BLEACH). This represents 12.4% of all adverse event reports for NIACINAMIDE.

159
Reports of Intentional product use issue with NIACINAMIDE
12.4%
of all NIACINAMIDE reports
148
Deaths
150
Hospitalizations

How Dangerous Is Intentional product use issue From NIACINAMIDE?

Of the 159 reports, 148 (93.1%) resulted in death, 150 (94.3%) required hospitalization, and 148 (93.1%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIACINAMIDE. However, 159 reports have been filed with the FAERS database.

What Other Side Effects Does NIACINAMIDE Cause?

Off label use (540) Drug ineffective (436) Pain (405) Nausea (380) Infusion related reaction (325) Malaise (324) Gastrooesophageal reflux disease (311) Dyspepsia (310) Headache (283) Condition aggravated (256)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which NIACINAMIDE Alternatives Have Lower Intentional product use issue Risk?

NIACINAMIDE vs NICARDIPINE NIACINAMIDE vs NICORANDIL NIACINAMIDE vs NICORETTE OTC NIACINAMIDE vs NICORETTE OTC, UNSPECIFIED NIACINAMIDE vs NICOTINE

Related Pages

NIACINAMIDE Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue NIACINAMIDE Demographics